Background Given excellent survival outcomes in breast cancer, there is interest in de‐
escalating the amount of chemotherapy delivered to patients. This approach may be of even …

Importance While the characteristics of COVID-19 infection and mortality among patients
with a malignant neoplasm have previously been examined, little data are available for …

During the acute phase of the COVID-19 pandemic, hospitals faced a challenge to manage
patients, especially those with other comorbidities and medical needs, such as cancer …

Background COVID‐19 infection delays therapy and in‐person evaluation for oncology
patients, but clinic clearance criteria are not clearly defined. Methods We conducted a …

Background Infectious diseases are a major cause of morbidity and mortality among cancer
patients. We aimed to determine the incidence of infectious diseases as a cause of death …

Disparities in cancer care and outcomes between racial and ethnic groups, urban and rural
populations, and socioeconomic classes are well documented and represent one of the …

Background The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …

Currently, many companies around the world are actively developing COVID-19 vaccines.
Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to …

The emergence of COVID-19 has created an unprecedented threat worldwide, involving
overwhelmed health-care systems in the majority of countries [1, 2]. Cancer screening and …

Background Due to the coronavirus disease 2019 (COVID-19) pandemic, patients may
encounter lung cancer care delays. Here, we sought to examine the impact of extended …